Posts Tagged: "Andrei Iancu"

New Clause 8 Episode: Andrei Iancu – From Communist Romania to USPTO Director

At the beginning of this year, IPWatchdog asked a panel of experts who should be the next USPTO Director. Almost every answer cited former USPTO Director Andrei Iancu as a model. Former Deputy USPTO Director Russ Slifer wrote: “Director Iancu worked with Congress and did not shy away from necessary reforms in Section 101 and the PTAB. Will the next Director be as successful? Hopefully, but Director Iancu is a difficult act to follow.” At the beginning of this year, IPWatchdog asked a panel of experts who should be the next USPTO Director. Almost every answer cited former USPTO Director Andrei Iancu as a model.

Iancu Weighs in on IP Waiver, Critical Role of Patents for SMEs at World IP Day Event

“Property rights are not just good for the economy, they save lives”, Grover Norquist, President of Americans for Tax Reform said, speaking at Innovating the Future: Celebrating 2021 World IP Day, sponsored by the Property Rights Alliance. Norquist would go on to conclude his brief opening remarks by lamenting, “the damage that would be done if some of the critics of intellectual property have their way.” Norquist was implicitly referring to an IP waiver proposal by South Africa and India, which would allow nations to ignore patent rights relating to COVID-19 related innovations, particularly vaccines. This waiver of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) is a truly bad idea, and one addressed head on by Andrei Iancu, senior adviser to the Renewing America Innovation Project at the Center for Strategic and International Studies and former Director of the United States Patent and Trademark Office (USPTO).

Iancu Says Goodbye, Urges Commitment to ‘American Innovation Renaissance’

One day before Joe Biden was to be inaugurated as the 46th U.S. President, U.S. Patent and Trademark Office (USPTO) Director Andrei Iancu confirmed he would be leaving his position as USPTO Director, reminiscing on his tenure with the Office in his latest Director’s Forum blog post and in remarks made at a United States Chamber of Commerce Global Innovation Policy Center event yesterday. Iancu recalled his successful efforts to clarify examination guidelines on patent eligibility and to balance post-grant proceedings, noting that, “In light of our many carefully-calibrated reforms, Senator Tillis recently said that the PTAB is no longer a death squad for patents. It is indeed a new day at the PTAB.” While many would not agree, it is generally accepted that Iancu’s administration has been a boon for patents, and the IP community will no doubt be sad to see him go.

USPTO Steps Into Social Media Controversy

The U.S. Patent and Trademark Office (USPTO) doesn’t often get much action on social media, but last week, five days before the U.S. Presidential election, the Office came under fire for its social media posts touting the United States’ record on intellectual property under the Trump Administration. The posts featured the following quote from USPTO Director Andrei Iancu: “Just a reminder, under President Trump’s leadership, the U.S. intellectual property ecosystem ranks #1 in the world, according to the 2020 International IP Index.”

PTAB Precedential Decision Nomination Form Could Lead to More Controversial Decision-Making Outside of Informal Rulemaking

In late September, Bloomberg News reported that Scott Boalick, Chief Administrative Patent Judge (APJ) at the Patent Trial and Appeal Board (PTAB), announced the introduction of a new form allowing members of the public the ability to nominate certain PTAB decisions for precedential status. The form, available on the U.S. Patent and Trademark Office’s website, asks those endorsing decisions to choose whether precedential or informative status should be conferred and to provide some brief reasons for the nomination. As Bloomberg’s coverage suggests, the anonymous nature of the process could encourage nominations from practitioners representing both patent owners and petitioners at the PTAB who may be concerned about how some clients may view their nominations. Such client overlap is a common feature at the PTAB, where many of the most active law firms representing patent owners are also atop the list of most active petitioners’ counsel.

Shira Perlmutter to Head U.S. Copyright Office

The U.S. Patent and Trademark Office (USPTO) announced today that Shira Perlmutter, the Office’s Chief Policy Officer and Director for International Affairs, has been chosen by Librarian of Congress Carla Hayden to be the 14th U.S. Register of Copyrights. Maria Strong has been serving as Acting Register since January 2020, after former Register Karyn Temple left the position in December 2019. Temple had been promoted to Register in March 2019 following two and a half years serving as Acting Register. Maria Pallante, the 12th Register of Copyrights, had been fired from the position in 2016.  

New USPTO Council Aims to Strengthen U.S. Innovation By Increasing Participation of Underrepresented Groups

The U.S. Patent and Trademark Office (USPTO) announced yesterday a major initiative to “build a more diverse and inclusive innovation ecosystem by encouraging participation demographically, geographically, and economically.” Dubbed the National Council for Expanding American Innovation (NCEAI), the project includes 29 representatives from industry, academia, and government, and was conceived based on recommendations made in the USPTO’s 2018 SUCCESS Act study and congressional report transmitted to Congress in December 2019.

IPWatchdog’s CON2020 Kicks Off with Andrei Iancu on 101, China, and Building Respect for IP

U.S. Patent and Trademark Office (USPTO) Director, Andrei Iancu, joined day one of Virtual CON2020 today to chat with IPWatchdog CEO and Founder Gene Quinn about topics including counterfeiting, Chinese IP theft, and the continued confusion in the courts and at the Patent Trial and Appeal Board (PTAB) around patent eligibility. On the topic of Section 101 and patent eligibility, Quinn lamented the recent American Axle decision, wondering if the holding that an invention involving a drive shaft could be considered directed to a law of nature represents a broader and growing disrespect for intellectual property. Iancu could not comment on the case itself, but said that with respect to the basic principle, “you’re absolutely right.

PTAB Rulemaking: Past, Present, and Future

Recently, the USPTO published a Notice of Proposed Rulemaking (NPRM) to change the “Trial Practice at the Patent Trial and Appeal Board,” which is contained in Part 42 of Title 37 of the Code of Federal Regulations. This is the fifth rule change since the Patent Trial and Appeal Board (PTAB) was created and the second of Director Iancu’s tenure. The first rules were issued on September 16, 2012, the one year anniversary of the America Invents Act. David Kappos was Director at the time. The first rules were controversial and heavily biased against inventors.

IBM Inventor Chieko Asakawa Named Inventor of the Year at IPO Education Foundation 2019 Awards Dinner

Last night at the Smithsonian American Art Museum and National Portrait Gallery, the old home of the original Patent and Trademark Office, the Intellectual Property Owners Education Foundation (IPOEF) held its annual Awards Dinner. The IPOEF Awards Dinner is one of the great industry events; an unapologetic celebration of innovation. Each year, this Awards Dinner recognizes the Inventor of the Year, as well as recognizing an IP Champion, Executive of the Year and youth winners of the IP Video Contest. Manny Schecter, Chief Patent Counsel for IBM and president of the IPOEF, began the awards program segment of the evening by saying what is undeniably true: this evening gives us the opportunity to put aside our differences and disagreements and “remember why it is that we do what we do and celebrate innovation.”

This Thanksgiving: What Is the IP Community Thankful For?

This year has included many twists and turns for IP stakeholders, particularly on the patent side. Most recently, the Federal Circuit’s decision in Arthrex has called into question the constitutionality of Patent Trial and Appeal Board decisions, and perhaps the Board itself. Elsewhere, Congress has been—unsuccessfully—attempting to step in and clarify U.S. patent law since early in the year, while the courts have continued to muddy the waters of patent eligibility law. The Federal Trade Commission’s case against Qualcomm, and Judge Lucy Koh’s decision in the case, have further called into question the United States’ ability to compete on the innovation front going forward. And yet, there have been some wins in other areas this year, including at the U.S. Patent and Trademark Office (USPTO), and there remain many reasons to be hopeful about the year ahead. IPWatchdog asked some IP experts to share what they have to be thankful for on the IP front this Thanksgiving, despite all the uncertainty. Hopefully, as those of you who celebrate the holiday enjoy your Thanksgiving dinners, these sentiments will inspire you to be thankful too.

Netlist Wins ITC Exclusion Order: Will the USPTO Support It?

Several weeks ago, the International Trade Commission (ITC) announced that Chief Administrative Law Judge (ALJ) Charles Bullock issued a Notice of Initial Final Determination recommending that certain memory modules manufactured and imported by SK Hynix, Inc. and its subsidiaries should be excluded from importation into the United States. As is common with these announcements, the ITC first released a one-page indication of the decision, which was followed by the redacted full decision once the parties had an opportunity to request redaction of trade secrets and confidential information. The full decision has now been released, and the ITC is asking for comments relating to public interest issues from the parties, interested persons, and other government agencies and departments.

What’s Next After Arthrex? Reactions Suggest Limited Immediate Effect, But Some Question Whether CAFC Fix Will Hold

The Federal Circuit’s decision in Arthrex, Inc. v. Smith & Nephew, Inc. generated excitement late last week, when many initially speculated that the Patent Trial and Appeal Board (PTAB) would not be able to continue operations as usual in light of the ruling. However, now that the dust has settled, it seems more likely that the effects of Arthrex will be limited to a small subset of cases. While he could not comment on next steps directly as it is a pending matter, USPTO Director Andrei Iancu suggested during a panel at the John Marshall Law School’s 63rd IP Conference in Chicago on Friday that the Office would not be significantly burdened by the decision. USPTO guidance is likely to be issued soon. Of course, the decision has not done much to bolster the already shaky reputation of the PTAB or its Administrative Patent Judges with some, and there are several scenarios in which the Federal Circuit’s quick fix to avoid shutting down the Board entirely might be challenged. Below are some early reactions to the ruling and predictions about how it may play out. 

Other Barks & Bites, Friday, September 27: CAFC Partially Vacates PTAB Decision, Colarulli Appointed to Head LESI, and Copyright Office Seeks Comments on Music Modernization Act

This week in Other Barks & Bites: the Federal Circuit issued a precedential decision reversing the PTAB regarding proper primary reference and CBM review findings; USPTO Director Iancu told IPO Annual Meeting attendees that subject matter eligibility guidelines are working; an EPO-EUIPO report shows IP-intensive industries contribute nearly half of EU GDP; the producers of the Broadway musical Hamilton have filed a motion to dismiss copyright claims filed in connection with a museum exhibit; eBay CEO Devin Wenig stepped down; the Ninth Circuit heard oral arguments in the en banc rehearing of the “Stairway to Heaven” copyright case; the U.S. Copyright Office is seeking public comments regarding the blanket licensing structure under the Music Modernization Act; and Sandoz has moved forward with a PTAB challenge on patent claims covering AbbVie’s Imbruvica.

Iancu Calls for Section 101 Fix in Address to AIPPI Congress

USPTO Director Andrei Iancu said “something has to be done about” Section 101, as it has been thrown into flux following various U.S. Supreme Court cases, in comments made at the AIPPI Congress in London, United Kingdom last week. Iancu took part in an hour-long discussion with AIPPI Reporter General John Osha, and also took questions from the audience last Monday. He addressed topics including AI, anti-IP sentiment, litigation costs, bad faith trademark filings and gender parity. But it was issues of patent eligibility that were chief on his mind. Iancu said the Administration “has tried to bring consistency and predictability” to Section 101 with its January 2019 guidance, but added: “Courts are independent. They don’t have to follow our guidance. And so far, I have seen no evidence that they want to.”